Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 411

1.

Increased Mortality after Tuberculosis Treatment Completion in Persons with HIV in Latin America.

Koenig SP, Kim A, Shepherd BE, Cesar C, Veloso V, Cortes CP, Padgett D, Crabtree-Ramírez B, Gotuzzo E, McGowan CC, Sterling TR, Pape JW; Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet).

Clin Infect Dis. 2019 Oct 20. pii: ciz1032. doi: 10.1093/cid/ciz1032. [Epub ahead of print]

PMID:
31629369
2.

LIFE EXPECTANCY DISPARITIES AMONG ADULTS WITH HIV IN THE UNITED STATES AND CANADA: THE IMPACT OF A REDUCTION IN DRUG- AND ALCOHOL-RELATED DEATHS USING THE LIVES SAVED SIMULATION (LISSO) MODEL.

Althoff KN, Chandran A, Zhang J, Arevalo WM, Gange SJ, Sterling TR, Gill MJ, Justice AC, Palella FJ Jr, Rebeiro PF, Silverberg MJ, Mayor AM, Horberg MA, Thorne JE, Rabkin CS, Mathews WC, Klein MB, Humes E, Lee J, Hogg R, Moore RD; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.

Am J Epidemiol. 2019 Oct 11. pii: kwz232. doi: 10.1093/aje/kwz232. [Epub ahead of print]

PMID:
31602475
3.

Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.

Gupta A, Montepiedra G, Aaron L, Theron G, McCarthy K, Bradford S, Chipato T, Vhembo T, Stranix-Chibanda L, Onyango-Makumbi C, Masheto GR, Violari A, Mmbaga BT, Aurpibul L, Bhosale R, Mave V, Rouzier V, Hesseling A, Shin K, Zimmer B, Costello D, Sterling TR, Chakhtoura N, Jean-Philippe P, Weinberg A; IMPAACT P1078 TB APPRISE Study Team.

N Engl J Med. 2019 Oct 3;381(14):1333-1346. doi: 10.1056/NEJMoa1813060.

PMID:
31577875
4.

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.

Stout JE, Sterling TR, Horsburgh CR Jr.

N Engl J Med. 2019 Sep 12;381(11):e23. doi: 10.1056/NEJMc1908492. No abstract available.

PMID:
31509689
5.

Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study.

Zürcher K, Ballif M, Kiertiburanakul S, Chenal H, Yotebieng M, Grinsztejn B, Michael D, Sterling TR, Ngonyani KM, Mandalakas AM, Egger M, Pettit AC, Fenner L; International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium.

J Int AIDS Soc. 2019 Sep;22(9):e25392. doi: 10.1002/jia2.25392.

6.

CD4/CD8 Ratio and CD4 Nadir Predict Mortality Following Noncommunicable Disease Diagnosis in Adults Living with HIV.

Castilho JL, Turner M, Shepherd BE, Koethe JR, Furukawa SS, Bofill CE, Raffanti S, Sterling TR.

AIDS Res Hum Retroviruses. 2019 Oct;35(10):960-967. doi: 10.1089/AID.2019.0064. Epub 2019 Sep 17.

PMID:
31407605
7.

Asynchronous Branch-Parallel Simulation of Detailed Neuron Models.

Magalhães BRC, Sterling T, Hines M, Schürmann F.

Front Neuroinform. 2019 Jul 23;13:54. doi: 10.3389/fninf.2019.00054. eCollection 2019.

8.

Trends and Disparities in Mortality and Progression to AIDS in the Highly Active Antiretroviral Therapy Era: Tennessee, 1996-2016.

Rebeiro PF, Pettit AC, Sizemore L, Mathieson SA, Wester C, Kipp A, Shepherd BE, Sterling TR.

Am J Public Health. 2019 Sep;109(9):1266-1272. doi: 10.2105/AJPH.2019.305180. Epub 2019 Jul 18.

PMID:
31318589
9.

Risk Factors for Tuberculosis and Effect of Preventive Therapy Among Close Contacts of Persons with Infectious Tuberculosis.

Reichler MR, Khan A, Sterling TR, Zhao H, Chen B, Yuan Y, Moran J, McAuley J, Mangura B; Tuberculosis Epidemiologic Studies Consortium Task Order 2 Team.

Clin Infect Dis. 2019 May 24. pii: ciz438. doi: 10.1093/cid/ciz438. [Epub ahead of print]

PMID:
31127813
10.

Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.

Lo Re V 3rd, Newcomb CW, Carbonari DM, Roy JA, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Hull M, Gill J, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Kim HN; North American AIDS Cohort Collaboration on Research and Design of IeDEA.

J Acquir Immune Defic Syndr. 2019 Sep 1;82(1):71-80. doi: 10.1097/QAI.0000000000002094.

PMID:
31107304
11.

Greater Weight Gain in Treatment Naïve Persons Starting Dolutegravir-Based Antiretroviral Therapy.

Bourgi K, Rebeiro PF, Turner M, Castilho JL, Hulgan T, Raffanti SP, Koethe JR, Sterling TR.

Clin Infect Dis. 2019 May 17. pii: ciz407. doi: 10.1093/cid/ciz407. [Epub ahead of print]

PMID:
31100116
12.

Increased vitamin D receptor expression from macrophages after stimulation with M. tuberculosis among persons who have recovered from extrapulmonary tuberculosis.

Fiske CT, Blackman A, Maruri F, Rebeiro PF, Huaman M, Kator J, Scott Algood HM, Sterling TR.

BMC Infect Dis. 2019 Apr 30;19(1):366. doi: 10.1186/s12879-019-3958-7.

13.

HIV-related tuberculosis: mortality risk in persons without vs. with culture-confirmed disease.

Crabtree-Ramírez B, Jenkins C, Jayathilake K, Carriquiry G, Veloso V, Padgett D, Gotuzzo E, Cortes C, Mejia F, McGowan CC, Duda S, Shepherd BE, Sterling TR.

Int J Tuberc Lung Dis. 2019 Mar 1;23(3):306-314. doi: 10.5588/ijtld.18.0111.

14.

Self-reported Cannabis Use and Changes in Body Mass Index, CD4 T-Cell Counts, and HIV-1 RNA Suppression in Treated Persons with HIV.

Lee JT, Saag LA, Kipp AM, Logan J, Shepherd BE, Koethe JR, Turner M, Bebawy S, Sterling TR, Hulgan T.

AIDS Behav. 2019 Feb 18. doi: 10.1007/s10461-019-02430-x. [Epub ahead of print]

PMID:
30778810
15.

Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.

Althoff KN, Gebo KA, Moore RD, Boyd CM, Justice AC, Wong C, Lucas GM, Klein MB, Kitahata MM, Crane H, Silverberg MJ, Gill MJ, Mathews WC, Dubrow R, Horberg MA, Rabkin CS, Klein DB, Lo Re V, Sterling TR, Desir FA, Lichtenstein K, Willig J, Rachlis AR, Kirk GD, Anastos K, Palella FJ Jr, Thorne JE, Eron J, Jacobson LP, Napravnik S, Achenbach C, Mayor AM, Patel P, Buchacz K, Jing Y, Gange SJ; North American AIDS Cohort Collaboration on Research and Design.

Lancet HIV. 2019 Feb;6(2):e93-e104. doi: 10.1016/S2352-3018(18)30295-9. Epub 2019 Jan 22. Erratum in: Lancet HIV. 2019 Apr 2;:.

PMID:
30683625
16.

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults.

Stacey HL, Rosen J, Peterson JT, Williams-Diaz A, Gakhar V, Sterling TM, Acosta CJ, Nolan KM, Li J, Pedley A, Benner P, Abeygunawardana C, Kosinski M, Smith WJ, Pujar H, Musey LK.

Hum Vaccin Immunother. 2019;15(3):530-539. doi: 10.1080/21645515.2018.1532249. Epub 2019 Jan 16.

PMID:
30648919
17.

Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.

Gras L, May M, Ryder LP, Trickey A, Helleberg M, Obel N, Thiebaut R, Guest J, Gill J, Crane H, Dias Lima V, dʼArminio Monforte A, Sterling TR, Miro J, Moreno S, Stephan C, Smith C, Tate J, Shepherd L, Saag M, Rieger A, Gillor D, Cavassini M, Montero M, Ingle SM, Reiss P, Costagliola D, Wit FWNM, Sterne J, de Wolf F, Geskus R; Antiretroviral Therapy Cohort Collaboration (ART-CC).

J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):292-300. doi: 10.1097/QAI.0000000000001913.

18.

Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study.

Cubillos-Angulo JM, Arriaga MB, Silva EC, Müller BLA, Ramalho DMP, Fukutani KF, Miranda PFC, Moreira ASR, Ruffino-Netto A, Lapa E Silva JR, Sterling TR, Kritski AL, Oliveira MM, Andrade BB.

Clin Infect Dis. 2019 Aug 30;69(6):1027-1035. doi: 10.1093/cid/ciy1001.

PMID:
30481307
19.

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

Peterson JT, Stacey HL, MacNair JE, Li J, Hartzel JS, Sterling TM, Benner P, Tamms GM, Musey LK.

Hum Vaccin Immunother. 2019;15(3):540-548. doi: 10.1080/21645515.2018.1532250. Epub 2018 Nov 14.

PMID:
30427749
20.

Treatment of drug-susceptible tuberculosis among people living with human immunodeficiency virus infection: an update.

Pettit AC, Shepherd BE, Sterling TR.

Curr Opin HIV AIDS. 2018 Nov;13(6):469-477. doi: 10.1097/COH.0000000000000506. Review.

21.

Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru.

Huaman MA, Henson D, Rondan PL, Ticona E, Miranda G, Kryscio RJ, Mugruza R, Aranda E, Ticona C, Abarca S, Heredia P, Aguirre A, Sterling TR, Garvy BA, Fichtenbaum CJ.

PLoS One. 2018 Sep 13;13(9):e0202191. doi: 10.1371/journal.pone.0202191. eCollection 2018.

22.

Early Retention in Care Neither Mediates Nor Modifies the Effect of Sex and Sexual Mode of HIV Acquisition on HIV Survival in the Americas.

Coelho L, Rebeiro PF, Castilho JL, Caro-Vega Y, Mejia FA, Cesar C, Cortes CP, Padgett D, McGowan CC, Veloso VG, Sterling TR, Grinsztejn B, Shepherd BE, Luz PM.

AIDS Patient Care STDS. 2018 Aug;32(8):306-313. doi: 10.1089/apc.2018.0028. Erratum in: AIDS Patient Care STDS. 2018 Sep 1;32(9):379.

23.

HIV-1 Transmission Clustering and Phylodynamics Highlight the Important Role of Young Men Who Have Sex with Men.

Dennis AM, Volz E, Frost ASMSDW, Hossain M, Poon AFY, Rebeiro PF, Vermund SH, Sterling TR, Kalish ML.

AIDS Res Hum Retroviruses. 2018 Oct;34(10):879-888. doi: 10.1089/AID.2018.0039. Epub 2018 Aug 23.

24.

Older age at first tuberculosis diagnosis is associated with tuberculosis recurrence in HIV-negative persons.

van der Heijden YF, Karim F, Chinappa T, Mufamadi G, Zako L, Shepherd BE, Maruri F, Moosa MS, Sterling TR, Pym AS.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):871-877. doi: 10.5588/ijtld.17.0766.

25.

Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.

Reichler MR, Khan A, Sterling TR, Zhao H, Moran J, McAuley J, Bessler P, Mangura B; Tuberculosis Epidemiologic Studies Consortium Task Order 2 Team.

J Infect Dis. 2018 Aug 14;218(6):1000-1008. doi: 10.1093/infdis/jiy265.

26.

Revealing the specificity of regulatory T cells in murine autoimmune diabetes.

Spence A, Purtha W, Tam J, Dong S, Kim Y, Ju CH, Sterling T, Nakayama M, Robinson WH, Bluestone JA, Anderson MS, Tang Q.

Proc Natl Acad Sci U S A. 2018 May 15;115(20):5265-5270. doi: 10.1073/pnas.1715590115. Epub 2018 Apr 30. Erratum in: Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):E5634.

27.

The relationship between adverse neighborhood socioeconomic context and HIV continuum of care outcomes in a diverse HIV clinic cohort in the Southern United States.

Rebeiro PF, Howe CJ, Rogers WB, Bebawy SS, Turner M, Kheshti A, McGowan CC, Raffanti SP, Sterling TR.

AIDS Care. 2018 Nov;30(11):1426-1434. doi: 10.1080/09540121.2018.1465526. Epub 2018 Apr 20.

PMID:
29678121
28.

Health Literacy and Demographic Disparities in HIV Care Continuum Outcomes.

Rebeiro PF, McPherson TD, Goggins KM, Turner M, Bebawy SS, Rogers WB, Brinkley-Rubinstein L, Person AK, Sterling TR, Kripalani S, Pettit AC.

AIDS Behav. 2018 Aug;22(8):2604-2614. doi: 10.1007/s10461-018-2092-7.

29.

Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV.

Elion RA, Althoff KN, Zhang J, Moore RD, Gange SJ, Kitahata MM, Crane HM, Drozd DR, Stein JH, Klein MB, Eron JJ, Silverberg MJ, Mathews WC, Justice AC, Sterling TR, Rabkin CS, Mayor AM, Klein DB, Horberg MA, Bosch RJ, Eyawo O, Palella FJ Jr; North American AIDS Cohort Collaboration on Research and Design of IeDEA.

J Acquir Immune Defic Syndr. 2018 May 1;78(1):62-72. doi: 10.1097/QAI.0000000000001642.

30.

Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.

Moro RN, Scott NA, Vernon A, Tepper NK, Goldberg SV, Schwartzman K, Leung CC, Schluger NW, Belknap RW, Chaisson RE, Narita M, Machado ES, Lopez M, Sanchez J, Villarino ME, Sterling TR.

Ann Am Thorac Soc. 2018 May;15(5):570-580. doi: 10.1513/AnnalsATS.201704-326OC.

31.

Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.

Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, Fätkenheuer G, Abgrall S, Saag MS, Del Amo J, Justice AC, Miro JM, Cavasinni M, Dabis F, Monforte AD, Reiss P, Guest J, Moore D, Shepherd L, Obel N, Crane HM, Smith C, Teira R, Zangerle R, Sterne JA, Sterling TR; Antiretroviral Therapy Cohort Collaboration (ART-CC) investigators.

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25031.

32.

Predicted Biological Activity of Purchasable Chemical Space.

Irwin JJ, Gaskins G, Sterling T, Mysinger MM, Keiser MJ.

J Chem Inf Model. 2018 Jan 22;58(1):148-164. doi: 10.1021/acs.jcim.7b00316. Epub 2017 Dec 29.

33.

Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Eberhardson M, Hall S, Papp KA, Sterling TM, Stek JE, Pang L, Zhao Y, Parrino J, Popmihajlov Z.

Clin Infect Dis. 2017 Oct 1;65(7):1174-1182. doi: 10.1093/cid/cix484.

PMID:
29126292
34.

The Relationship Between Latent Tuberculosis Infection and Acute Myocardial Infarction.

Huaman MA, Ticona E, Miranda G, Kryscio RJ, Mugruza R, Aranda E, Rondan PL, Henson D, Ticona C, Sterling TR, Fichtenbaum CJ, Garvy BA.

Clin Infect Dis. 2018 Mar 5;66(6):886-892. doi: 10.1093/cid/cix910.

35.

Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America.

Engels EA, Yanik EL, Wheeler W, Gill MJ, Shiels MS, Dubrow R, Althoff KN, Silverberg MJ, Brooks JT, Kitahata MM, Goedert JJ, Grover S, Mayor AM, Moore RD, Park LS, Rachlis A, Sigel K, Sterling TR, Thorne JE, Pfeiffer RM; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

Clin Infect Dis. 2017 Aug 15;65(4):636-643. doi: 10.1093/cid/cix392.

36.

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).

Trickey A, May MT, Schommers P, Tate J, Ingle SM, Guest JL, Gill MJ, Zangerle R, Saag M, Reiss P, Monforte AD, Johnson M, Lima VD, Sterling TR, Cavassini M, Wittkop L, Costagliola D, Sterne JAC; Antiretroviral Therapy Cohort Collaboration (ART-CC).

Clin Infect Dis. 2017 Sep 15;65(6):959-966. doi: 10.1093/cid/cix466.

37.

Tuberculosis Meningitis.

Bourgi K, Fiske C, Sterling TR.

Curr Infect Dis Rep. 2017 Sep 11;19(11):39. doi: 10.1007/s11908-017-0595-4. Review.

PMID:
28895024
38.

Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens.

Norwood J, Turner M, Bofill C, Rebeiro P, Shepherd B, Bebawy S, Hulgan T, Raffanti S, Haas DW, Sterling TR, Koethe JR.

J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):527-531. doi: 10.1097/QAI.0000000000001525.

39.

Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas.

Crabtree Ramírez B, Caro Vega Y, Shepherd BE, Le C, Turner M, Frola C, Grinsztejn B, Cortes C, Padgett D, Sterling TR, McGowan CC, Person A.

Int J Infect Dis. 2017 Oct;63:57-63. doi: 10.1016/j.ijid.2017.08.004. Epub 2017 Aug 12.

40.

Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population.

Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, Burkholder GA, Mathews WC, Silverberg MJ, Sterling TR, Heckbert SR, Budoff MJ, Van Rompaey S, Delaney JAC, Wong C, Tong W, Palella FJ, Elion RA, Martin JN, Brooks JT, Jacobson LP, Eron JJ, Justice AC, Freiberg MS, Klein DB, Post WS, Saag MS, Moore RD, Crane HM.

J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):568-576. doi: 10.1097/QAI.0000000000001450.

41.

Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.

van der Heijden YF, Karim F, Mufamadi G, Zako L, Chinappa T, Shepherd BE, Maruri F, Moosa MS, Sterling TR, Pym AS.

Int J Tuberc Lung Dis. 2017 Jun 1;21(6):670-676. doi: 10.5588/ijtld.16.0843.

42.

Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.

Dubrow R, Qin L, Lin H, Hernández-Ramírez RU, Neugebauer RS, Leyden W, Althoff KN, Achenbach CJ, Hessol NA, Modur SP, DʼSouza G, Bosch RJ, Grover S, Horberg MA, Kitahata MM, Mayor AM, Novak RM, Rabkin CS, Sterling TR, Goedert JJ, Justice AC, Engels EA, Moore RD, Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):382-390. doi: 10.1097/QAI.0000000000001394.

43.

The need for randomised controlled trials of isoniazid monoresistant tuberculosis treatment.

Otero L, Villegas L, Huamán M, Sterling T, Seas C.

Lancet Infect Dis. 2017 Apr;17(4):363-364. doi: 10.1016/S1473-3099(17)30121-4. No abstract available.

PMID:
28346171
44.

Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada.

Rebeiro PF, Abraham AG, Horberg MA, Althoff KN, Yehia BR, Buchacz K, Lau BM, Sterling TR, Gange SJ.

AIDS Patient Care STDS. 2017 Mar;31(3):129-144. doi: 10.1089/apc.2016.0178. Epub 2017 Feb 27.

45.

Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.

Sterling TR.

Int J Tuberc Lung Dis. 2016 Dec 1;20(12):42-47. doi: 10.5588/ijtld.16.0117.

PMID:
28240572
46.

Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV-Infected Persons Engaged in HIV Care.

Kipp AM, Rebeiro PF, Shepherd BE, Brinkley-Rubinstein L, Turner M, Bebawy S, Sterling TR, Hulgan T.

AIDS Behav. 2017 Jul;21(7):1996-2004. doi: 10.1007/s10461-017-1716-7.

47.

Tuberculosis and risk of acute myocardial infarction: a propensity score-matched analysis.

Huaman MA, Kryscio RJ, Fichtenbaum CJ, Henson D, Salt E, Sterling TR, Garvy BA.

Epidemiol Infect. 2017 May;145(7):1363-1367. doi: 10.1017/S0950268817000279. Epub 2017 Feb 16.

48.

Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.

Moro RN, Sterling TR, Saukkonen J, Vernon A, Horsburgh CR, Chaisson RE, Hamilton CD, Villarino ME, Goldberg S.

Int J Tuberc Lung Dis. 2017 Mar 1;21(3):286-296. doi: 10.5588/ijtld.16.0469. Epub 2017 Jan 13.

49.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL.

Clin Infect Dis. 2017 Jan 15;64(2):111-115. doi: 10.1093/cid/ciw778.

50.

Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities.

McAnaw SE, Hesseling AC, Seddon JA, Dooley KE, Garcia-Prats AJ, Kim S, Jenkins HE, Schaaf HS, Sterling TR, Horsburgh CR.

Int J Infect Dis. 2017 Mar;56:194-199. doi: 10.1016/j.ijid.2016.11.423. Epub 2016 Dec 9. Review.

Supplemental Content

Loading ...
Support Center